Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05911750

Prevalence and Clinical Implications of HPV Infection in Male IBD Patients

Prevalence and Clinical Implications of Human Papillomavirus Infection in the Male Population With Inflammatory Bowel Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
384 (estimated)
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
Sex
Male
Age
18 Years – 79 Years
Healthy volunteers
Not accepted

Summary

The study aims at describing the prevalence of Human Papillomavirus (HPV) infection in anal and oral samples of men with Inflammatory Bowel Disease (IBD) and detecting risk factors for the infection.

Detailed description

Male IBD patients attending the IBD Clinic of Hospital de la Santa Creu i Sant Pau will be screened for eligibility. Informed consent will be obtained from all eligible patients. An anal and oral swab will be performed on all patients to look for HPV infection (HPV DNA test) and cytologic alterations. Patients will be inspected to rule out the presence of HPV-related lesions. Moreover, a self-administered questionnaire will be completed by all enrolled patients. Information regarding IBD characteristics and treatment will be obtained. According to local practice, patients with anal or oral squamous intraepithelial lesions (ASIL) will be referred to a colorectal surgeon for further recommendations or treatment.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAnal pap smear and oral swab for cytology and HPV testingAnal and oral swab sampling for HPV detection (polymerase chain reaction) and cytology

Timeline

Start date
2023-02-12
Primary completion
2026-01-31
Completion
2026-06-01
First posted
2023-06-22
Last updated
2025-09-12

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05911750. Inclusion in this directory is not an endorsement.